GAMCO INVESTORS, INC. ET AL - VANECK VECTORS ETF TR ownership

VANECK VECTORS ETF TR's ticker is GDX and the CUSIP is 92189F106. A total of 703 filers reported holding VANECK VECTORS ETF TR in Q3 2023. The put-call ratio across all filers is 0.70 and the average weighting 0.4%.

Quarter-by-quarter ownership
GAMCO INVESTORS, INC. ET AL ownership history of VANECK VECTORS ETF TR
ValueSharesWeighting
Q3 2023$1,371,065
-12.3%
50,950
-1.9%
0.02%0.0%
Q2 2023$1,564,215
-6.9%
51,9500.0%0.02%
-11.1%
Q1 2023$1,680,583
+12.9%
51,9500.0%0.02%
+12.5%
Q4 2022$1,488,887
+18.8%
51,9500.0%0.02%
+6.7%
Q3 2022$1,253,000
-11.9%
51,9500.0%0.02%
-6.2%
Q2 2022$1,422,000
-31.3%
51,950
-3.7%
0.02%
-15.8%
Q1 2022$2,069,000
+19.7%
53,950
-0.0%
0.02%
+26.7%
Q4 2021$1,728,000
-5.8%
53,951
-13.3%
0.02%
-6.2%
Q3 2021$1,835,000
-13.4%
62,252
-0.2%
0.02%
-11.1%
Q2 2021$2,119,000
+4.6%
62,3520.0%0.02%0.0%
Q1 2021$2,026,000
-11.6%
62,352
-2.0%
0.02%
-14.3%
Q4 2020$2,293,000
-8.1%
63,652
-0.2%
0.02%
-25.0%
Q3 2020$2,496,000
+74.4%
63,750
+63.4%
0.03%
+75.0%
Q2 2020$1,431,000
+59.2%
39,0250.0%0.02%
+45.5%
Q1 2020$899,000
-25.2%
39,025
-4.9%
0.01%
+10.0%
Q4 2019$1,202,000
+14.3%
41,050
+4.2%
0.01%
+11.1%
Q3 2019$1,052,000
+4.5%
39,4000.0%0.01%
+12.5%
Q2 2019$1,007,00039,4000.01%
Other shareholders
VANECK VECTORS ETF TR shareholders Q3 2023
NameSharesValueWeighting ↓
Memorial Sloan Kettering Cancer Center 738,500$19,873,03580.92%
New Harbor Financial Group, LLC 1,680,752$45,229,03314.96%
TORQ CAPITAL MANAGEMENT (HK) Ltd 139,000$3,740,4909.95%
Vanderbilt University 1,360,540$36,612,1319.45%
Eschler Asset Management LLP 300,000$8,073,0009.42%
New Harbor Financial Group, LLC 1,027,300$27,644,6439.15%
Guild Investment Management, Inc. 139,333$3,749,4546.28%
Monaco Asset Management SAM 750,000$20,182,5005.98%
STRATEGIC INVESTMENT MANAGEMENT, LLC 132,460$3,867,8324.74%
PCG Wealth Advisors, LLC 264,614$7,120,7824.67%
View complete list of VANECK VECTORS ETF TR shareholders